Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

BioWatch RFI – Trigger/Detector Capability

by Global Biodefense Staff
December 19, 2014
BioWatch Trigger Detector

The Department of Homeland Security (DHS) has issued a new Request for Information (RFI) in support of the BioWatch program.

The effort seeks to determine the current state of technologies that can provide a Biological Trigger/Detector added to the BioWatch sample collection process.

The item would be used in conjunction with current or future collection and identification technology and would serve to reduce the time to detect and improve BioWatch operational performance.

A successful candidate technology will have the ability to:

  • Detect indicators of potential biological agents within one minute
  • Detect these indicators at low concentrations with a high degree of confidence
  • Distinguish biological agent indicators from inorganic material and environmental background (dirt, brake dust, construction material, etc.)
  • Demonstrate a low rate of false positives and false negatives
  • Operate in a wide variety of indoor physical environments (e.g., office buildings, mass transit facilities), Ability to operate in outdoor environments
  • Transmit results and system status electronically and be controlled remotely

Further details are available via Solicitation Number: HSHQDC-15-I-11103. The response deadline is January 30, 2015.

Companion BioWatch RFIs were also simultaneously released for related areas including: Autonomous Indoor Sampling Systems, Portable Biological Identifier Systems, Aerosol Collection and Alternatives to PCR Detection.

Tags: BioterrorismBioWatchDHSHomeland SecurityRFISample Collection

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
Why Do Some of the Outbreak Genomes Have More Mutations Than Others?
Biosurveillance

Virginia Institutes Partner to Join National Pathogen Genomics Centers of Excellence Network

October 25, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC